Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
Woo, P., Wilkinson, N., Prieur, A-M., Southwood, T., Leone, V., Livermore, P., Wythe, H., Thomson, D. and Kishimoto, T.
(2005)
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement.
ISSN 1478-6354
-
picture_as_pdf - 901524.pdf
-
- Available under Creative Commons: 4.0
Downloads